Get the Daily Brief
Latest Biotech News
Gilead Expands In Vivo CAR-T Therapy With Interius Acquisition
Gilead Sciences has acquired Interius BioTherapeutics for $350 million, gaining a platform for in vivo CAR-T cell therapies. This single-shot approach potentially allows genetic modification of...
Ionis Gets FDA Nod for Hereditary Angioedema Drug
Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), a prophylactic therapy targeting hereditary angioedema (HAE), a rare and potentially life-threatening genetic disorder...
Sarepta Therapeutics’ Debt Refinancing Extends Financial Flexibility
Sarepta Therapeutics announced refinancing transactions that delay approximately $700 million of convertible senior notes due in 2027, extending maturities to 2030 and beyond. This move...
Brain Maps Remain Stable After Limb Amputation, Study Shows
A collaborative study involving the University of Pittsburgh and University College London reveals that the human brain’s cortical body maps remain remarkably stable even years after arm...
Artificial Intelligence Enhances Cancer and Neonatal Diagnostics
Multiple studies highlight AI’s transformative role in healthcare diagnostics. New AI models predict tumor microRNA expression in kidney cancer and pulmonary hemorrhage in preterm infants....
Novel Immunotherapies and Cancer Mechanisms Unveiled
Innovative cancer research reveals mechanisms and therapies reshaping oncology. Bispecific innate cell engager AFM28 targets CD123+ leukemic stem cells in AML and MDS, offering new immunotherapy...
FDA's Revised Approach Impacts Rare Disease Therapeutics
The FDA’s expedited review for Stealth BioTherapeutics’ Barth syndrome therapy signals a regulatory shift benefiting rare disease treatments. Following multiple delays and rejections, a planned...
Advances in Metabolic and Immunotherapy Research in Cancer
Recent breakthroughs shed light on metabolic and immune pathways in cancer. Targeting spermine metabolism enhances pancreatic cancer immunity, potentially improving immunotherapies. Meanwhile,...
Graphene Accelerates Brain Organoid Maturation, Unlocking Neurodegenerative Disease Modeling
Researchers at the University of California, San Diego Sanford Stem Cell Institute have developed a groundbreaking Graphene-Mediated Optical Stimulation (GraMOS) technique that uses graphene's...
Gilead Joins In Vivo CAR-T Race with $350M Interius Buyout
Gilead Sciences’ subsidiary Kite Pharma has acquired Interius BioTherapeutics for $350 million, gaining proprietary in vivo CAR-T cell therapy technology that enables genetic modification of...
FDA Approvals and Regulatory Updates in Rare and Genetic Diseases
Ionis Pharmaceuticals achieved FDA approval for Dawnzera (donidalorsen), a prophylactic treatment for hereditary angioedema (HAE), marking its second rare disease approval within a year. The...
Advanced Artificial Intelligence Enhances Drug Discovery and Diagnostics
Cutting-edge AI technologies continue to revolutionize biotechnology, as exemplified by several breakthroughs. MIT researchers developed a generative AI model that proposed over 10 million novel...
Breakthroughs in Cancer Immunotherapy and Tumor Microenvironment
Recent studies highlight critical advances in understanding and enhancing cancer immunotherapy. Research reveals that anti-PD-1 treatment significantly improves outcomes in gastric cancer patients...
New Molecular and Genetic Insights in Cancer Progression and Therapy
Cutting-edge research has revealed novel molecular mechanisms driving cancer progression and potential therapeutic targets. Studies identify the GATOR1 complex as a potent tumor suppressor in...
Revolutionary AI-Driven Innovations Transform Bioprocessing and Manufacturing
The biopharmaceutical manufacturing landscape is undergoing profound transformation driven by artificial intelligence and digital technologies. Industry leaders like Sanofi demonstrate how...
Innovative AI and ML Applications Enhance Biotech R&D and Healthcare
Artificial intelligence and machine learning are making significant inroads across biotech research and healthcare delivery. OpenAI’s new model scored a gold medal at the International Math...
Breakthrough Neuroscience Reveals Brain Stability and Therapeutic Targets
Novel neuroscience research challenges longstanding notions of brain plasticity and opens pathways to innovative therapies. Multiple studies show that the brain’s somatosensory body map remains...
Significant Advancements in Biotech Financing, Partnerships, and Regulatory Moves
Recent financial and strategic developments demonstrate continued investment and restructuring in the biotech sector. Calidi Biotherapeutics successfully closed a $6.9 million public offering to...
Graphene-Enabled Neurodevelopment Model: Accelerated Brain Organoid Maturation
Researchers at the University of California San Diego have developed a novel graphene-mediated optical stimulation (GraMOS) technique that accelerates the maturation of human brain organoids. This...
FDA Approvals and Corporate Financial Moves in Rare Diseases and Biotech
Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), a prophylactic therapy for hereditary angioedema (HAE), marking the company's second recent approval for the rare disease....